Latest stories on ELDN
Eledon Pharmaceuticals presents patient-reported outcomes data from BESTOW trial
The Fly58 · neutralproduct/pr
Eledon Pharmaceuticals Announces Presentation at the American Society of Nephrology Kidney Week 2026 Annual Meeting
Business Insider56 · neutralproduct/pr
Eledon Pharmaceuticals Announces Presentation at the American Society of Nephrology Kidney Week 2026 Annual Meeting
GlobeNewswire56 · neutralproduct/pr
Eledon Pharmaceuticals, Inc. (ELDN) Presents at International Congress of The Transplantation Society 2026 - Slideshow
Seeking Alpha50 · neutralgeneral
Eledon rises on new mid-stage trial data, FDA fast track status for lead drug
Seeking Alpha67 · bullishproduct/pr
Eledon Shares Rise on Fast-Track Designation for Kidney Treatment
Morningstar67 · bullishproduct/pr
ELDN jumps after tegoprubart shows a 13 mL/min/1.73 m eGFR edge at 24 months and earns FDA Fast Track status
September 22, 2026
MarketChameleon73 · bullishproduct/pr
Eledon Pharmaceuticals updates long-term data from Phase 2 BESTOW trial
The Fly63 · neutralproduct/pr
Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society
GlobeNewswire56 · neutralproduct/pr
Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society
StockTitan56 · neutralproduct/pr
Eledon files islet cell transplant application, plans Phase 3 kidney trial
The Fly63 · neutralproduct/pr
Eledon Pharmaceuticals GAAP EPS of -$0.27 misses by $0.11
Seeking Alpha34 · bearishearnings
Eledon Pharmaceuticals, Inc. (ELDN) files 8-K
SEC 8-K50 · neutralgeneral
Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire50 · neutralearnings
Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights
StockTitan50 · neutralearnings
Eledon: At The Center Of The Next Medical Frontier
Seeking Alpha73 · bullishproduct/pr
Eledon’s BESTOW Trial Completion: What Tegoprubart Could Mean for Transplant Investing
TipRanks65 · bullishproduct/pr
Eledon Pharmaceuticals stock initiated at Buy by Rodman & Renshaw
Investing.com Analyst Ratings61 · neutralanalyst